Loading...
Galapagos and Cancer Research Technology announce new anti-cancer drug discovery collaboration
20-Jan-2006
Advertisement
Galapagos NV and Cancer Research Technology ("CRT") announced that they have entered into a new collaboration in anti-cancer drug discovery research. Under the terms of the agreement Galapagos' service division BioFocus will perform medicinal chemistry services on a series of CRT anti-cancer drug programs. In return, CRT will fund the work of four BioFocus scientists throughout 2006.